Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-048274
Filing Date
2015-08-12
Accepted
2015-08-12 07:00:54
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v417157_10q.htm 10-Q 337695
2 EXHIBIT 31.1 v417157_ex31-1.htm EX-31.1 8779
3 EXHIBIT 31.2 v417157_ex31-2.htm EX-31.2 8791
4 EXHIBIT 32.1 v417157_ex32-1.htm EX-32.1 4529
  Complete submission text file 0001144204-15-048274.txt   2418686

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cltx-20150630.xml EX-101.INS 491134
6 XBRL TAXONOMY EXTENSION SCHEMA cltx-20150630.xsd EX-101.SCH 26970
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cltx-20150630_cal.xml EX-101.CAL 22587
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cltx-20150630_def.xml EX-101.DEF 136882
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cltx-20150630_lab.xml EX-101.LAB 181784
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cltx-20150630_pre.xml EX-101.PRE 164197
Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036
Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804
Celsus Therapeutics Plc. (Filer) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: 10-Q | Act: 34 | File No.: 001-36288 | Film No.: 151045521
SIC: 2834 Pharmaceutical Preparations